(Q40877118)

24 September 2017

1 reference

title

Hormone replacement therapy and cancer (English)

1 reference

Hormone Replacement Therapy

24 September 2017

main subject

1 reference

Mack TM

1

1 reference

24 September 2017

language of work or name

1 reference

1 January 1993

1 reference

Bailliere's clinical endocrinology and metabolism

24 September 2017

published in

1 reference

24 September 2017

volume

7

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

113-149

1 reference

Long-term consequences of estrogen and estrogen-progestin replacement

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Plasma estrogen in patients with endometrial hyperplasia and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Effects on breast tissue of exogenous oestrogens and progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Ovarian cancer.Incidence and case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial cancer and estrogen use. Report of a large case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oestrogen therapy after the menopause--boon or bane?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Smoking and estrogen-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Hormone replacement and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Malignant melanoma and oral contraceptive use among women in California

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oral contraceptive use and malignant melanoma in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Two pathogenetic types of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk factors for ovarian cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Carcinoma of the uterine corpus. A study of 269 cases. 1947 to 1959

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Menopausal oestrogens and breast cancer risk: an expanded case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The adverse effects of hormonal therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The epidemiology of cardiovascular disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The impact of long term estrogen support after hysterectomy. A report of 1016 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Fibroadenoma and the use of exogenous hormones. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

"Incessant ovulation" and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oral contraceptives and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Survival among women with endometrial cancer: a comparison of estrogen users and nonusers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Socioeconomic distribution of cancer of the female sex organs in New Haven

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oestrogen use and survival in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Trends in the incidence of endometrial cancer in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Trends in the incidence of endometrioid and clear cell cancers of the ovary in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Safety of post-menopausal hormone replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial Carcinoma after Stilbestrol Therapy in Gonadal Dysgenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

HRT: an analysis of benefits, risks and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Progesterone concentrations in samples of saliva from adolescent girls living in Britain and Thailand, two countries where women are at widely differing risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Geographic variation in declining ischemic heart disease mortality in the United States, 1968-1978. I. Rates and change, whites aged 35-74 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Exacerbation of intermittent claudication by propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endocrine factors in endometrial carcinoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Suitability of the beagle dog as a test model for the tumorigenic potential of contraceptive steroids “short review”

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Epidemiology of Endometrial Cancer 2

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Benefits and risks of menopausal estrogen and/or progestin hormone use.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Trends in the incidence of cancer of the corpus uteri in Denmark, 1943-1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial cancer following treatment for breast cancer: a case-control study in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The joint effect of risk factors on endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A genetic linkage study of familial breast-ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk factors for epithelial ovarian cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Postmenopausal smoking, estrogen replacement therapy, and the risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial carcinoma in previously ovariectomized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Role of progestogens in the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Use of progestogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Sex hormones and postmenopausal breast cancer: a prospective study in an adult community.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Reproductive factors, exogenous female hormones, and colorectal cancer by subsite

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The socioeconomic distribution of cancer of various sites in Buffalo, N.Y., 1948-1952

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The protective role of progesterone in the prevention of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Pelvic irradiation and tamoxifen as risk factors for carcinoma of corpus uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The benefits and risks of hormone replacement therapy: An epidemiologic overview

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A case-control study of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The cancer question: an overview of recent epidemiologic and retrospective data

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The epidemiology of endometrial cancer in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Exogenous estrogen and breast cancer after bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

An epidemiologic study of epithelial carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen use - risk of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Menopausal Estrogens and Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Cancer of the uterine corpus after hormonal treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Alternative analytic methods for case-control studies of estrogens and endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogens and endometrial cancer. Responses to arguments and current status of an epidemiologic controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growth

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Hormone-replacement therapy and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Breast cancer and estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

1 reference

7 January 2021

Effects of time and duration of progesterone administration on mammary tumours induced by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Clinical studies concerning the relationship of estrogens to the development of cancer of the corpus uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Replacement estrogens and endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Conjugated estrogens and fibrocystic breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Effect of a systemically administered progestogen on histopathology of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Non-contraceptive estrogen use and the risk of gallstone disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Noncontraceptive estrogen use and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Breast cancer and the pill--a further report from the Royal College of General Practitioners' oral contraception study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A case-control study of cancer of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Adenocarcinoma of the endometrium in women aged forty and younger

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A case-control study of cancer of endometrium in Athens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk factors for adenomatous endometrial hyperplasia: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial carcinoma following estrogen-progestogen therapy in Turner's syndrome a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Prognostic features of endometrial cancer in estrogen users and obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oestrogens and obesity as risk factors for endometrial cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Incessant Ovulation and Ovarian Cancer: A Critical Approach

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Non-contraceptive oestrogens and the risk of breast cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Non-contraceptive oestrogens and breast cancer: An update

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Smoking, body weight, and early-stage endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Early-age body size, adult weight gain and endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial cancer and age at last delivery: evidence for an association

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risks of estrogens and progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A correlative morphologic study of human breast and endometrium in the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Familial association of breast/ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The rising frequency of hysterectomy: its effect on uterine cancer rates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Proliferative stimuli in the normal breast: estrogens or progestins?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Exogenous estrogen and endometrial carcinoma: Case-control and incidence study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Menopausal estrogen use and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The woman at risk for developing ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Reserpine and Breast Cancer in a Retirement Community

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogens and Endometrial Cancer in a Retirement Community

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk factors for endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Age at menarche, probability of ovulation and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Survival experience of aged hip fracture patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Recent trends in the incidence and mortality of cancer of the uterine corpus in Connecticut

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Cyclic Variation of DNA synthesis in human breast epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Antiestrogen action of progesterone in breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Hormone replacement therapy and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk/benefit considerations of antiestrogen/estrogen therapy in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Breast cancer incidence is on the rise--but why?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The association of replacement estrogens with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Postmenopausal oestrogen treatment and stroke: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Hormone replacement therapy in the menopause: a suitable animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen replacement therapy and fibrocystic breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial disease after treatment with oestrogens and progestogens in the climacteric

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Sex differences in declining cohort death rates from heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Recent time trends in uterine cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The risk of endometrial and breast cancer after estrogen treatment. A review of epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Reproductive factors and colon cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oral contraceptives and breast cancer: is the CASH study really negative?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial polyps and hyperplasia as risk factors for endometrial carcinoma. A case-control study of curettage specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Menstruation span--a time-limited risk factor for endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Climacteric symptoms and estrogen replacement therapy in women with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Association of a History of Gallbladder Disease with a Reduced Concentration of High-Density-Lipoprotein Cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Increased risk of cholecystectomy in users of supplemental estrogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen use and stroke risk in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

1 reference

7 January 2021

Comparison of urinary and plasma hormone levels in daughters of breast cancer patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Events of reproductive life and the incidence of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Non-contraceptive exogenous oestrogen therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial cancer and its precursors: a comparison of histological and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Prevention of endometrial hyperplasia in postmenopausal women with intrauterine progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial carcinoma in women under 40 years of age: comparison of cases in oral contraceptive users and non-users

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Effects of smoking on the development of female reproductive cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endocrine abnormalities accompanying human endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Hormone replacement therapy induced chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The Recent Decline in Ischemic Heart Disease Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Incidence of Endometrial Carcinoma in King County, Washington: A Standardized Histologic Review: Brief Communication2

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Nutritional and endocrine factors in reproductive organ cancers: opportunities for primary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. A study of ethnic Chinese women in the Orient and the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Induction of Human Endometrial Estradiol Dehydrogenase by Progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial carcinoma: The effect of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oral contraceptives and breast cancer: final report of an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Temporal and regional variation in hysterectomy rates in the United States, 1970--1975.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Prolonged estrogen therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Cost-effectiveness of hormone replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Assessing the risks from menopausal estrogen use: what can we learn from trends in mortality from uterine cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Increasing Incidence of Endometrial Cancer in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Endometrial cancer in relation to patterns of menopausal estrogen use.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Oestrogens and endometrial cancer: effect of other risk factors on the association.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Epidemiologic study of malignancies of the ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Controversies concerning the safety of estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Serum equilin, oestrone, and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens ('Premarin')

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

The roles of estrogen and progesterone in breast and genital cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Geographic and socioeconomic variation in the onset of decline of coronary heart disease mortality in white women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

An epidemiological investigation of cancer of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Epidemiology of cancer of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Noncontraceptive hormone use and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980273-3

7 January 2021

10.1016/S0950-351X(05)80273-3

Identifiers

DOI

1 reference

24 September 2017

1 reference